Drugs / DMT210 Topical Gel
last change Jul 2017 re-read 3 minutes ago

DMT210 Topical Gel

Developed for
atopic eczema
Investigated by
Dermata Therapeutics

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02949960 Oct 2016 → Jul 2017 atopic eczema Dermata Therapeutics Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DMT210 Topical Gel ClinicalTrials.gov intervention name — accepted as the source's own label NCT02949960 ↗
Route Topical “DMT210 Topical Aqueous Gel 5% applied twice daily” NCT02949960 ↗